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leptin resistance.
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Leptin is a hormone produced by the adipose tissue
that acts in the brain, stimulating white fat break-
down. We find that the lipolytic effect of leptin is
mediated through the action of sympathetic nerve
fibers that innervate the adipose tissue. Using
intravital two-photon microscopy, we observe that
sympathetic nerve fibers establish neuro-adipose
junctions, directly ‘‘enveloping’’ adipocytes. Local
optogenetic stimulation of sympathetic inputs in-
duces a local lipolytic response and depletion of
white adipose mass. Conversely, genetic ablation
of sympathetic inputs onto fat pads blocks leptin-
stimulated phosphorylation of hormone-sensitive
lipase and consequent lipolysis, as do knockouts of
dopamine b-hydroxylase, an enzyme required for
catecholamine synthesis. Thus, neuro-adipose junc-
tions are necessary and sufficient for the induction of
lipolysis in white adipose tissue and are an efferent
effector of leptin action. Direct activation of sympa-
thetic inputs to adipose tissues may represent an
alternative approach to induce fat loss, circumvent-
ing central leptin resistance.
INTRODUCTION
White adipose tissues (WATs) serve as a storage depot for en-
ergy-rich triglycerides. In times of privation, this lipid storage
can be released as part of an adaptive response to the energy
shortage. Lipolysis, the process of hydrolyzing stored triglycer-
ides in adipocytes, is regulated by several G-protein-coupled
receptors, including adrenergic receptors, all of which activate
protein kinase A (PKA) and elevate the intracellular levels of cy-
clic adenosine monophosphate (cAMP) (Brasaemle, 2007).
PKA also phosphorylates several key target proteins, including84 Cell 163, 84–94, September 24, 2015 ª2015 Elsevier Inc.lipid-droplet-associated protein perilipin, hormone-sensitive
lipase (HSL), and a set of esterases that collectively promote
the hydrolysis of triglycerides into free fatty acids (FFAs) and
glycerol, which are then released into plasma to meet the energy
demands of other tissues (Brasaemle, 2007). HSL is a canonical
target of PKA in adipocytes, and this enzyme catalyzes the con-
version of diacylglycerol to monoacyl glycerol (Brasaemle,
2007).
Adipose tissuemass is homeostatically controlled by an endo-
crine loop in which leptin acts on neural circuits in the hypothal-
amus and elsewhere in brain to regulate food intake and periph-
eral metabolism (Friedman and Halaas, 1998). In wild-type (WT)
and leptin-deficient ob animals, leptin treatment reduces food
intake and leads to a rapid depletion of fat mass (Halaas et al.,
1995, 1997; Montez et al., 2005). Of note, the depletion of fat
mass after leptin treatment is distinct from that observed after
food restriction in a number of respects: leptin treatment spares
lean body mass and also potently stimulates glucose meta-
bolism, while starvation results in a loss of lean body mass and
causes insulin resistance (Newman and Brodows, 1983; Koffler
and Kisch, 1996; Awad et al., 2009; Elia et al., 1999). In addition,
leptin-deficient ob/ob mice pair-fed to leptin-treated ob mice
lose only half the weight of those treated with leptin, further impli-
cating a mechanism beyond a reduced food intake (Rafael and
Herling, 2000). Because leptin has been shown to increase the
sympathetic efferent signal to brown adipose tissues (BAT)
(Scarpace and Matheny, 1998; Rezai-Zadeh and Mu¨nzberg,
2013), it has been suggested that leptin also activates sympa-
thetic efferents to WAT to increase lipolysis in WAT. However,
this has not been directly shown, and the nature of the effector
mechanism underlying leptin-stimulated lipolysis in WAT has
not been defined. In particular, it has not been established
whether the increased lipolysis in WAT in response to leptin is
due to a circulating hormone (or hormones) such as norepineph-
rine (NE) and/or another mediator that is released either centrally
or peripherally (adrenal gland or macrophages), or specific
efferent neural inputs to WAT, which mediates central leptin ac-
tion. However, the effect of leptin on energy balance does not
Figure 1. Leptin Stimulates HSL Phosphor-
ylation in WAT
(A) Immunostaining of p-HSL (red) in paraffin
sections of epididymal fat of C57Bl6/J mice that
were peripherally administrated with 500 ng/hr
recombinant leptin for 2 days.
(B) p-HSL and phosphorylated PKA substrates in
total protein extracts of epididymal fats were
examined by immunoblot analysis.require the presence of intact adrenals, suggesting that this
organ is unlikely to be the source of the lipolytic signal (Arvaniti
et al., 1998).
While numerous previous studies have shown dense neural
innervation of BAT, both functionally and anatomically, the inner-
vation of WAT has been difficult to visualize. Thus, it has been
suggested that neural inputs to WAT are either very sparse or
difficult to be distinguished from en passant axons with terminals
on other cell types, such as those in vasculature (Bartness et al.,
2005; Bartness and Song, 2007; Youngstrom and Bartness,
1995; Giordano et al., 1996). Indeed, some reports have sug-
gested that the only innervation of WAT is perivascular and
that white adipocytes themselves are not directly innervated
(Giordano et al., 2005). This controversy has heightened the
uncertainty as to the relative roles of sympathetic neural activity
to regulate WAT metabolism. Alternatively, macrophages in ad-
ipose tissue account for about 10% of the stromal vascular frac-
tion (SVF); hence, local catecholamines produced by these cells
could also contribute to lipolysis in WAT in vivo (Weisberg et al.,
2003; Nguyen et al., 2011). Thus, the dramatic decrease of adi-
pose tissue mass observed after leptin treatment could, in prin-
ciple, be mediated by catecholamines or other mediators that
are either locally produced or produced by neurons.
In this study, we use anatomic, optogenetic, biochemical, and
genetic approaches to show that the catecholamines released at
heretofore-unidentified neuro-adipose junctions mediates the
lipolytic effect of leptin, thus establishing the effector mechanism
underlying the depletion of fat mass by leptin and, potentially,
other stimuli. Our data demonstrate that the local sympathetic
activity in WAT is necessary and sufficient for the lipolytic effect
of leptin. In addition, genetic evidence shows that the b-adren-
ergic, but not a-adrenergic, receptors partially constitute a
signaling pathway that accounts for the lipolytic effect of leptin.
Moreover, the effect of pre-synaptic manipulations, such as neu-
ral gain of function or loss of function, is more profound than that
of post-synaptic manipulations, thus suggesting direct activa-Cell 163, 84–94, Stion of sympathetic inputs to adipose tis-
sues as a strategy for the induction of fat
loss.
RESULTS
Phosphorylation of HSL in WAT as a
Lipolysis Marker for Leptin Action
Todirectly assess thecellular effect of lep-
tin on lipolysis in white adipocytes and
provide a marker for leptin action, wesearched for biochemical responses in white adipocytes that
were specifically activated by leptin treatment.We used a battery
of phospho-specific antibodies and found that the phosphoryla-
tion of HSL was robustly increased in adipose tissue in response
to leptin treatment.Note that our ability to defineabiochemical ef-
fect of leptin is dependent on the quality of the antibodies, andwe
found that the anti-pHSL antibody was extremely robust. As
shown, peripheral administration of leptin led to a significant in-
crease of phosphorylatedHSL (p-HSL) inWAT that could be visu-
alized by immunohistochemistry (Figure 1A) and quantified by
immunoblot analysis (Figure 1B). We set out to investigate
whether the effect of leptin to increase HSL phosphorylation
was mediated by neural efferent outputs onto WAT.
Axonal Bundles Project to WAT and Form Sympathetic
Neuro-adipose Junctions
We first used tomography methods to determine whether fat
pads were innervated. By coupling optical projection tomogra-
phy (OPT) to a fat-clearing method that renders whole organs
transparent, we were able to macroscopically visualize and
document the nerve bundles that innervate the inguinal fat pad
(Figure 2A; Experimental Procedures; Supplemental Experi-
mental Procedures for details) (Gualda et al., 2013; Quintana
and Sharpe, 2011). A full series of projections of the whole
organ are acquired from multiple angles, typically 800–1,600
angles, and from this series of projections, a stack of axial
slices can be visualized through back-projection reconstruction
(Figure 2B).
From an OPT series of coronal optical sections of inguinal fat
organ, we performed a 3D reconstruction, which enabled the
visualization of thick axon bundles targeting the fat pad (Figures
2C and 2D). Axon bundles can be identified based on the gray
threshold level and morphological features that distinguish
them from the vasculature (Figure 2E). These structures within
the fat were then segmented using semi-automated software
(see Experimental Procedures).eptember 24, 2015 ª2015 Elsevier Inc. 85
Figure 2. Neural Projections in Fat Detected with OPT
(A) Schematic representation of the OPT method applied to the subcutaneous inguinal fat. (i) Tissue dissection. (ii) Sample clearing. (iii) Image acquisition. (iv)
Sinogram transformation. (v) 3D reconstruction and segmentation.
(B) OPT series of coronal sections of inguinal fat organ after 3D reconstruction.
(C) Orthogonal 400-mm OPT slabs of inguinal fat in coronal, axial, and sagittal views. Axon bundles were identified based on the gray threshold level (arrows).
(D) 3D reconstruction in maximal intensity projection of the OPT coronal sections.
(E) Surface view of segmented structures within inguinal fat.The neural bundles weremicro-dissected from the subcutane-
ous fat pads and subjected to immunostaining for tyrosine hy-
droxylase (TH), a marker of sympathetic neurons, and b3-tubulin
(Tub-3), a generalmarker for theperipheral nervous system (PNS)
(Figure 3A). We found that, overall, 50% of the Tub-3-positive
neurons also expressed TH, thus establishing the presence of
both catecholaminergic andnon-catecholaminergic axons inner-
vating subcutaneous fat pads (Figure 3A). Then, we used multi-
photon microscopy on the intact inguinal WAT of a living mouse
to visualize sympathetic neuro-adipose connections (Figures
3B and 3C; Experimental Procedures). We labeled adipocytes
with LipidTOX, a lipophylic dye, and sympathetic axons by
crossingTHCre-recombinasemice (TH-Cre) with aTdtomato-re-
porter line (Rosa26-LSL-Tdtomato) (Figure 3C).Weobserved that
Tdtomato-positive axons in fat pads made dense contacts with
adipocytes through bouton-like structures that had the anatomic
appearance of neuro-adipocyte junctions, resembling synapses
(Figure 3C). We quantified these from eight independent two-
photon micrographs and determined that 8% ± 4.6% of adipo-
cytes are in direct contact with sympathetic nerves.86 Cell 163, 84–94, September 24, 2015 ª2015 Elsevier Inc.Optogenetic Stimulation of Sympathetic Inputs to WAT
Leads to Catecholamine Release, HSL Phosphorylation,
and Fat Mass Depletion
We assessed the function of the catecholaminergic fibers by
crossing the TH-Cremice to a channelrhodopsin (ChR2) reporter
line, Rosa26-LSL-ChR2-YFP. ChR2-YFP (yellow fluorescent
protein) showed a complete co-localization with the endogenous
TH, as determined by immunostaining of YFP and TH (Figure 4A).
ChR2-YFP-expressing axons that projected onto subcutaneous
WAT were then optogenetically activated using a subcutane-
ously implanted optical fiber targeting the right inguinal fat depot
(see Experimental Procedures for surgical details).
While optogenetic tools have been widely used in the CNS, it
has not been used as frequently to probe the function of periph-
eral cells, including sympathetic neurons. We began by vali-
dating the use of optogenetic stimulation of sympathetic neurons
in primary cultures of superior cervical ganglia (SCG) of TH-Cre X
Rosa26-LSL-ChR2-YFP mice; SCG can be dissected with less
difficulty compared to other sympathetic ganglia (see Supple-
mental Experimental Procedures for culture details). We found
Figure 3. Catecholaminergic Neurons
Innervating Adipocytes Integrate Nerve
Bundles of Mixed Molecular Identity
(A) Partial co-localization of TH (red), an SNS
marker, and Tub-3 (green), a general PNS marker,
shown by immunohistochemistry of nerve bundles
dissected from the inguinal fat pads of WT mice.
Scale bars, 50 mm.
(B) Schematic representation of the two-
photon intra-vital imaging of neurons in the
inguinal fat pad.
(C) Intra-vital two-photonmicroscopy visualization
of a neuro-adipose connection in the inguinal
fat pad of a live TH-Cre; LSLS-Tomato mouse;
LipidTOX (green) labels adipocytes. Scale bar,
100 mm.that optogenetic stimulation of cultured sympathetic neurons
increased expression of c-Fos, a marker for neuronal activity,
in TH-positive cells and significantly stimulated NE release
ex vivo, as assayed with ELISA (Figures 4B and 4C). NE release
of ChR2-positive neurons was significantly higher relative to that
of ChR2-negative cells (749.6 ± 170.1 pg/ml versus 4.8 ± 1.7 pg/
ml, p < 0.05) (Figures 4B and 4C; see Experimental Procedures
for culture and stimulation details).
Next, we stimulated ChR2-YFP-expressing axons in vivo
unilaterally by placing optical fibers subcutaneously, aiming at
inguinal fat pads located in the supra-pelvic flank of TH-Cre X
Rosa26-LSL-ChR2-YFP mice (see Experimental Procedures for
stimulation details). Activation of the ChR2-positive axons in
subcutaneousWAT led to a significant increase of NE in the stim-
ulated fat pad, relative to the contralateral un-stimulated control
side (2.7 ± 0.5 versus 1.1 ± 0.2, p < 0.05; Figure 4D). We also
observed a significant increase of HSL phosphorylation of fat
on the side ipsilateral to the optical fiber, compared to the
contralateral un-stimulated side (Figure 4E). These data show
that local activation of catecholaminergic inputs to fat could
locally mimic the biochemical effect of leptin (Figures 4D and
4E). Then, we tested whether a more prolonged (4-week) opto-
genetic stimulation of ChR2-positive neurons in WAT could
deplete fat mass (Figure 4F). The optical stimulation protocol
was set to deliver light for every other second at 20 Hz, andCell 163, 84–94, Sthe volume of subcutaneous WAT was
determined using MRI with 3D recon-
struction (Figures 4F and 4G; see Experi-
mental Procedures for details). After
chronic activation, the size of the optoge-
netically stimulated ipsilateral fat pads
of TH-Cre; Rosa26-LSL-ChR2-YFP mice
was 23% ± 3.4% that of the contralateral
control side, representing a statistically
and biologically significant decrease
in fat mass (Figures 4F and 4G, p <
0.0001). This effect depended on ChR2
expression, as the fat pad volume of stim-
ulated fat pads in ChR2-negative mice
was unchanged (86% ± 4.3% of the size
of the contralateral control fat pad), rulingout a potential nonspecific effect of laser stimulation (Figure 4G;
see Experimental Procedures for details). Together, the results
provide anatomical and functional evidence that there are syn-
apse-like sympathetic inputs onto white adipocytes and that
their activation is sufficient to promote local NE release, HSL
phosphorylation, and a reduction in the mass of an adipose
tissue depot.
Local Sympathetic Inputs Are Required for
Leptin-Stimulated HSL Lipolysis in WAT
Similarly to optogenetic stimulation of sympathetic innervation
in white fat, leptin treatment led to an increase in NE levels in
the subcutaneous adipose organ. NE levels in WATs dissected
from leptin-treated animals were significantly higher than those
in controls (78.7 ± 16.8 pg NE/mg of protein versus 30.7 ± 4.1
pg NE/mg of protein, p < 0.05; Figure 5A). Interestingly, leptin
treatment did not affect serum NE levels (Figure 5B), indicating
that leptin locally increases NE release in white fat, but not
systemically.
Next, we evaluated whether sympathetic activation is neces-
sary for leptin-stimulated lipolysis by disrupting the neural inputs
in WAT, using a pharmacologic blockade or local genetic abla-
tion. First, we observed that administration of hexamethonium,
a non-depolarizing anti-cholinergic ganglion blocker, signifi-
cantly decreased the leptin-stimulated phosphorylation of HSLeptember 24, 2015 ª2015 Elsevier Inc. 87
Figure 4. Optogenetic Stimulation of SNS Neurons in Fat Is Sufficient to Drive Lipolysis
(A) Complete co-localization of YFP (green) and TH (red) shown by immunohistochemistry of nerve bundles dissected from the inguinal fat pads of TH-Cre; LSLS-
ChR2-YFP. Scale bars, 50 mm.
(B) c-Fos (green) induction in cultured SNS neurons after optogenetic activation. Scale bars, 10 mm.
(C) Ex vivo NE release upon optogenetic stimulation of sympathetic SCG explants isolated from TH-Cre; LSL-ChR2-YFPmice and LSL-ChR2-YFP control mice
(*p < 0.05; n = 3–6). Results are shown as mean ± SEM.
(D) In vivo NE release in subcutaneous fat upon optogenetic stimulation of sympathetic neurons in WATs of TH-Cre; LSL-ChR2-YFP and LSL-ChR2-YFP control
mice that were subcutaneously implanted with optical fibers targeting the inguinal fat pad (*p < 0.05; n = 8). Results are shown as mean ± SEM.
(E) Immunoblot analysis of p-HSL in total protein extracts of subcutaneous fats of TH-Cre; LSL-ChR2-YFP and LSL-ChR2-YFP control mice that were subcu-
taneously implanted with optical fibers targeting the inguinal fat pad and optogenetically stimulated for 2 weeks (details are given in Experimental Procedures).
(F) MRI-guided visualization of fat in TH-Cre; LSL-ChR2-YFP and LSL-ChR2-YFP control mice that were optogenetically stimulated for 4 weeks (yellow indicates
control inguinal fat pat, blue indicates light-stimulated fat pad; details are given in Experimental Procedures).
(G) Quantification of fat reduction in stimulated side versus the contralateral control side (****p < 0.0001; n = 6). Results are shown as mean ± SEM.
See also Movies S1 and S2.in adipose tissue (Figure 5C). However, as the action of hexame-
thonium is systemic and is not cell type specific, affecting all
ganglionic transmission, we took a complementary approach
by introducing a local neural crush injury to the fibers innervating
epididymal fat pads. Because of the anatomy of the fat pad,
nerve fibers in the distal portion of the tissues can be efficiently
eliminated by a surgical crush of the perivascular axons running
parallel to the main vessels (see Experimental Procedures). We
carried out physical denervation with a forcep crushing the fibers
2 mm from the distal tip for 30 s. Leptin was delivered 3 days
post-surgery through osmotic pump for 2 days. Consistent
with the effect of hexamethonium, after a crush injury to the local
nerve, leptin treatment failed to increase HSL phosphorylation on
the denervated side compared to the intact contralateral control88 Cell 163, 84–94, September 24, 2015 ª2015 Elsevier Inc.(Figure 5D). This showed that local neural activation to WAT
is required for the biochemical changes associated with leptin
treatment.
To confirm that leptin-mediated lipolysis is the result of activa-
tion of sympathetic neural outputs to fat, we ablated these
neurons by crossing the TH-Cre line with the diphtheria toxin re-
ceptor (DTR) mice, Rosa26-LSL-DTR, and injected diphtheria
toxin (DT) locally in subcutaneous inguinal WAT (Buch et al.,
2005). Local treatment with DT eliminated only those sympa-
thetic axons in the regions of the injection site, without effects
on other local neuronal populations as shown by the sparing
TH-negative Tub-3-positive axons at the site of injection (Fig-
ure 5E, p < 0.001; see Supplemental Experimental Procedures
for details). These injections were administered peripherally at
Figure 5. Sympathetic Neurons Are Locally Required for Leptin-Induced Lipolysis
(A and B) C57BL6/J mice were peripherally administrated with 500 ng/hr recombinant leptin or saline for 2 days. (A) NE content in subcutaneous fat pads (*p <
0.05; n = 5) and (B) NE serum levels were measured by NE ELISA (n = 4). Results are shown as mean ± SEM. ns, not significant.
(C and D) C57BL6/Jmice were peripherally administrated with 500 ng/hr recombinant leptin (C) in combination with 500 mg/hr ganglionic blocker hexamethonium
(Hexam.) or (D) at 3 days after local crush injury of nerves in fat pads. p-HSL in total protein extracts of epididymal fats were examined by immunoblot analysis.
(E) Fat pads in TH-Cre; LSL-DTRmice were locally treated with DT. Tissue-specific ablation of SNS axons confirmed by immunostaining for Tub-3 and TH (**p <
0.001; n = 6). Results are shown as mean ± SEM.
(F) Immunoblot analysis of p-HSL in total protein extracts of subcutaneous fats of TH-Cre; LSL-DTR and control mice injected with DT following leptin treatment
(500 ng/hr).
See also Figure S1.low doses (10 ng/g) to ensure that the effect was local and to also
spare TH-positive neurons in CNS (Figure S1; Domingos et al.,
2013). Genetic ablation of sympathetic input to adipose tissue
completely blocked the effect of leptin on HSL phosphorylation
on the ipsilateral compared to the contralateral untreated side
(Figure 5F). Together, these results demonstrate that activation
of sympathetic neurons in fat is necessary for leptin to stimulate
HSL phosporylation in adipose tissue.
b-Adrenergic Signaling Influences Leptin-Stimulated
Lipolysis in WAT
Consistent with a sympathetic mechanism for the leptin-medi-
ated stimulation of lipolysis, systemic administration of the
b-adrenergic agonist isoproterenol resulted in the rapid induc-
tion of p-HSL. As previously reported, isoproterenol also
increased FFA release from WAT in vitro and in vivo (Figure S2).
Therefore, we set out to test whether b-adrenergic signaling was
required for leptin-stimulated lipolysis.
We first examined the lipolytic response to leptin in mice with a
knockout (KO) of dopamine b-hydroxylase (DBH), a key enzyme
in the synthesis of NE and epinephrine from dopamine (Figure 6).After peripheral administration of leptin, there was a dramatic
increase of HSL phosphorylation in WAT in the WT or DBH+/+
animals but a markedly diminished response in the DBH/
littermates (Figure 6A). Consistent with this, the total fat compo-
sition dramatically decreased in the WT mice treated with
leptin, while there was only a slight change of fat mass in mice
with the DBH deletion (p < 0.05; Figure 6B). Also consistent
with a diminished lipolytic effect of leptin, there was also a lower
amount of weight loss in the DBH/ mice (Figure 6C). After
2 days of leptin treatment, the body weight of WT mice
decreased more than 6%, while the weight loss of DBH/
was less than 2% (p < 0.05). The data suggest that catechol-
amines contribute to more than 50% of leptin’s effect on body
weight. Altogether, the results confirm that catecholamines are
required for the leptin-stimulated lipolysis and HSL phosphoryla-
tion in WAT.
To test whether the action of leptin to drive lipolysis is medi-
ated through b-adrenergic signaling, we crossed the b1/b2
double-KO to b3 KO to generate animals with a deletion of all
three b-adrenergic receptors (Figure 7). Animals with a deletion
of all three isoforms of the b-adrenergic receptors showedCell 163, 84–94, September 24, 2015 ª2015 Elsevier Inc. 89
Figure 6. Norepinephrine Deficiency Im-
pairs Leptin-Induced Lipolysis
(A) Immunoblot analysis of p-HSL in total protein
extracts of fat pads of dopamine b-monoxygenase
mutant and control littermates (DBH/ and
DBH+/+, respectively) mice that were treated with
500 ng/hr recombinant leptin.
(B) Whole-body fat composition (*p < 0.05).
Results are shown as mean ± SEM (n = 4–5).
(C) Body weight change after leptin treatment (*p <
0.05). Results are shown as mean ± SEM (n = 5).significantly decreased HSL phosphorylation after leptin treat-
ment in comparison to the double-KO controls (Figure 7A). How-
ever, this decrease was not as marked as that seen in individual
depots after local ablation of sympathetic fibers using DT (Fig-
ure 5F). While leptin treatment significantly decreased total fat
mass in b1/b2/ mice, this effect was significantly reduced
in b1/b2/b3/ triple-KO mice (Figure 7B; paired ANOVA
post hoc test, p < 0.01, comparing b1/b2/b3/ with
b1/b2/b3+/+ mice after leptin treatment). In contrast,
a-adrenergic receptors appeared to play only a minor role in
the leptin-stimulated loss of fat mass, because the a-adrenergic
blockers phentolamine (5 mg/kg, intraperitoneally [i.p.]) and phe-
noxybenzamine (10 mg/kg i.p.) failed to diminish the catabolic
responses to leptin treatment in b1/b2/b3+/+ control mice
or b1/b2/b3/ mice (Figure 7C). There was also a small
suppression of body weight loss in response to leptin in the
b1/b2/b3/ mice (Figure 7D). These results showed that
the b-adrenergic receptors are only partially necessary for lep-
tin-mediated lipolysis ofWAT but that themagnitude of the effect
of a loss of b-adrenergic signaling is not as great as that
observed by interfering with local neural outputs, thus suggest-
ing that there could also be other neural mediators or interacting
receptors on adipocytes (Figure 5).
DISCUSSION
Leptin is known to stimulate lipolysis and reduce fat mass,
though the physiologic mechanisms responsible for this have
not been fully delineated. In this study, we present data using
functional, anatomic, biochemical, and genetic approaches to
show that leptin increases lipolysis via the actions of sympathetic
neuronal efferents to adipose tissue. These data also provide
molecular, cellular, and anatomic evidence confirming the exis-90 Cell 163, 84–94, September 24, 2015 ª2015 Elsevier Inc.tence of neuronal projections onto adipo-
cytes, which have been the subject of
conjecture but which have not been
directly visualized.
The existence of neuro-adipose junc-
tions in WAT had been inferred based
on the fact that a pseudorabies retro-
grade-tracing virus can visualize a set of
neural projections in the brain (Bartness
and Song, 2007). In addition, immunohis-
tochemistry, and immunofluorescence
have been used to visualize contacts be-tween sympathetic neurons and adipocytes in sliced tissue
(Giordano et al., 1996, 2005; Thompson, 1986). However, these
methods, which require tissue slicing and fixation, do not distin-
guish en passant neurons from those that directly project onto
adipocytes. The visualization of adipocyte-projecting neurons
that can completely envelop an adipocyte has not been accom-
plished so far. We were able to directly visualize neural termini
onto adipocytes using intra-vital multiphoton microscopy, which
allows deep penetrance onto the live intact tissue, allowing us to
visualize deeper structures without the perturbations associated
with classical histological methods, which, in past studies, may
have compromised the integrity of the neuro-adipose termini
(Helmchen and Denk, 2005).
Confocal or multiphoton microscopy methods are suitable for
histological analysis at a microscopic spatial scale, but do not
give a 3D perspective of the organization of the organ as awhole.
At a macroscopic spatial scale, methods such as MRI or
computed tomography (CT) allow for measurement of whole-
body fat distribution. However, all of these methods lack the
spatial resolution that is required for visualizing structures such
as nerve bundles. OPT is a technique with physical principles
similar to those of X-ray CT/gamma radiation, which uses visible
light instead of radiation (Gualda et al., 2013). Scattering of light
passing through tissues is minimized by clearing lipids from the
whole organ (Quintana and Sharpe, 2011). Unlike most currently
available methods, OPT coupled to tissue clearing allows imag-
ing of whole-mount samples with a spatial scale in the order of
centimeters.
It has been previously shown that electrical stimulation of WAT
nerve bundles can drive lipolysis (Correll, 1963). However, as
shown here, nerve bundles in WAT have mixed molecular iden-
tity, making it difficult to ascertain the identity of the neurons
responsible for this effect. To address this limitation, we used
Figure 7. Deficiency of All b-Adrenergic Receptors Influences Leptin-Induced Lipolysis
(A) Immunoblot analysis of p-HSL in total protein extracts of fat pads of b1/b2/b3+/+ and b1/b2/b3/mice that were treated with 500 ng/hr recombinant
leptin.
(B) Whole-body fat composition (*p < 0.05, n = 4–5). Results are shown as mean ± SEM.
(C) a-Adrenergic receptors had a minor function in leptin-induced lipolysis (*p > 0.05, n = 4–5). Results are shown as mean ± SEM. ns, not significant.
(D) Whole-body fat composition of mice peripherally treated with recombinant leptin and a-blockers (phentolamine, 5 mg/kg, i.p.; and phenoxybenzamine,
10 mg/kg, i.p.) was measured (n = 4–5). Results are shown as mean ± SEM.
See also Figure S2.optogenetics, which allows for cell-specific stimulation of neu-
rons (Domingos et al., 2011, 2013). In the present study, we
used optogenetics to specifically activate sympathetic neurons
in TH-Cremice. Another advantage of this approach is that it en-
ables the specific activation of axonal projections and does not
require stimulation of neuronal cell bodies (Petreanu et al.,
2007; Vrontou et al., 2013). This feature is particularly convenient
for autonomic neurons, given the deep localization of their cell
bodies along the anterior face of the spinal cord and the intrinsic
difficulty of implanting optical fibers in this location. Previous
studies using neural tracing have revealed that sympathetic neu-
rons innervating the subcutaneous inguinal fat pads localize
to the 13th thoracic ganglia, which localizes at the dorsal edge
of the diaphragm muscle, in the transition between the thorax
and the abdomen (Youngstrom and Bartness, 1995). This
anatomical location is particularly inaccessible and unsuitable
for chronic implants of optical fibers or equivalent devices. How-
ever, as we show here, subcutaneous implant of optical fibers for
stimulation of nerve terminals is feasible and effective. We used
this approach to show that optogenetic gain of function of the
catecholaminergic signaling to the neuro-adipose junction can
lead to thephosphorylationofHSLand lipolysis ofWAT.Similarly,
previous loss-of-function experiments that assessed the effect ofsympathetic input on lipolysis also did not allow analysis of the
effect of specific cells in the way that optogenetics can. Thus,
the use of mechanical denervation does not distinguish between
neurons that directly innervate adipocytes versus those that are
passing through. We have not yet profiled the non-TH nerve fi-
bers, but it is reasonable to expect that somemight be parasym-
pathetic, nociceptive, sensory fibers and/or en passant axons.
The function of these fibers could be assessed similarly to those
that we report, using optogenetics, to activate other populations,
including cholinergic neurons, by studyingcholineacetyltransfer-
ase (ChAT)-Cre mice and/or neurons expressing other molecular
markers.Chemical ablationwith capsaicin alsohas limitations, as
this treatment is not specific to sympathetic neurons and affects
all transient-receptor-potencial-vaniloid (TRPV)-expressing fi-
bers (Holzer, 1991). Chemical ablation with 6-hydroxydopamine
is likely to affect dopaminergic as well as enteric neurons,
creating secondary systemic effects (Ding et al., 2004).
To avoid these limitations and gain local control over sympa-
thetic neural activity, we used additional molecular genetic tools
that combine tissue specificity with a localized effect. We show
that ablation of the sympathetic neurons by DTR expression in
TH-positive neurons followed by local DT injection in WAT abol-
ishes the effect of leptin on HSL phosphorylation. We also notedCell 163, 84–94, September 24, 2015 ª2015 Elsevier Inc. 91
that the loss of function due to post-synaptic manipulations (i.e.,
the triple b-adrenergic receptor KO in Figure 7) has a lesser effect
on the size of adipose tissue depots than that seen after pre-syn-
aptic manipulations such as a loss of DBH or pharmacologic or
mechanical ablation of neural input to fat (Figure 6). This sug-
gests that leptin-induced production of NE from sympathetic
neurons could act through additional receptors that are not
one of the three b-adrenergic receptors that we tested, which
have been suggested by others (Tavernier et al., 2005). Alterna-
tively, sympathetic neurons may co-release other neurotrans-
mitters or neuropeptides that signal through non-adrenergic
receptors. This could account for the residual leptin-induced
weight loss seen in DBH/, although this effect is not significant
when compared to controls. Thus, an in-depth knowledge of the
underlying sympathetic neural circuits could provide strategies
to pharmacologically activate specific sympathetic neuronal
population, thus circumventing leptin resistance, as potential
treatment of obesity.
A canonical effect of leptin is to increase sympathetic signaling
to BAT, thus promoting thermogenesis (Bachman et al., 2002;
Landsberg et al., 1984). However the role of autonomic stimula-
tion of white fat has been less well studied.We now show that the
sympathetic activity is also responsible for the leptin-stimulated
lipolysis inWAT.While leptin has been assumed to increase lipol-
ysis via activation of sympathetic efferent fibers, this has not
been directly shown. Adrenergic agonists have been shown to
induce the formation of beige (brite) fat, and these data suggest
that sympathetic innervation may also stimulate this phenotypic
change in adipose tissue (Bachman et al., 2002; Giralt and Villar-
roya, 2013; Dempersmier et al., 2015). Consistent with this, leptin
has also been suggested to increase the formation of beige fat
(Dodd et al., 2015).
Because brown adipocytes have relatively smaller fat storages
compared to white adipocytes, while having higher metabolic
demand, the continuous thermogenic response of BAT might
require the supply of FFA from WAT mobilized in other parts of
the body. Therefore, it is reasonable to speculate that the coor-
dinated sympathetic actions in BAT and WAT in response to
leptin could help maximize the hormone’s effect on energy
expenditure and fat metabolism. Future studies delineating the
neural circuits connecting the central action of leptin with the
peripheral activation of sympathetic system will be necessary
to test this hypothesis. Particularly, it would be of great impor-
tance to develop technologies that would allow whole-body
visualization and mapping of peripheral neuronal circuits using
some of the approaches presented here.
In summary, we provide direct evidence that the sympathetic
neuro-adipose junction is both necessary and sufficient for leptin
to drive lipolysis in WAT.
EXPERIMENTAL PROCEDURES
Antibodies and Drugs
The antibodies were obtained from the following vendors: HSL (Cell Signaling
Technology), phospho-HSL (Cell Signaling Technology), phospho-PKA sub-
strate (Cell Signaling Technology), TH (Pel-Freez Biologicals), and actin
(Sigma). Hexamethonium chloride, phentolamine, and phenoxybenzamine
were from Sigma-Aldrich. DT was purchased from Merck Millipore. Recombi-
nant mouse leptin was obtained from Amylin Pharmaceuticals.92 Cell 163, 84–94, September 24, 2015 ª2015 Elsevier Inc.Mice
DBH KO mice were kindly provided by Steve Thomas at the University of
Pennsylvania.Adrb1/2/ andAdrb3/were kindly provided byBruce Spie-
gelmanatHarvardMedical School. TH-Cre, Rosa26-LSL-ChR2-YFP (StockNo.
012-569; Daou et al., 2013), Rosa26-LSL-DTR, and C57BL/B6J mice at
6–10 weeks old were purchased from The Jackson Laboratory. Animal proce-
dureswere approvedby theethics committeeof InstitutoGulbenkiandeCieˆncia
and the Institutional Animal Care and Use Committee of Rockefeller University.
OPT
Six-week-old C57BL/6 mice were sacrificed with carbon dioxide. The inguinal
fat pads were dissected from the mice with Dumont #5 Forceps, fixed in 4%
paraformaldehyde (PFA; Sigma-Aldrich) for 3 hr at room temperature (RT)
and subjected to the OPT clearing protocol as described in the Supplemental
Experimental Procedures. Images of the whole fat tissue were acquired using
a 13 lens mounted on an Infinitube tube lens and projected into a Hamamatsu
FlashLT sCMOS camera. A total of 1,600 images were acquired for a full
rotation (0.25 steps). The series of projections were then pre-processed for
back-projection using FIJI in order to remove hot pixels and re-align the axis
of rotation in relation to the camera chip, and finally the back-projection recon-
struction was conducted using the Skyscan’s NRecon software (Schindelin
et al., 2012). The stack of slices was further processed with FIJI to increase
contrast and saved to posterior analysis with the software Amira V5.3. Using
this software, 3D reconstructions and image segmentation were performed
to identify and reconstruct individual parts of the fat organs. Detailed instruc-
tions for setting up an OPT system can be found at https://sites.google.com/
site/openspinmicroscopy/home/opt.
In Vivo Two-Photon Microscopy
Two-month-old mice were kept anesthetized with 2% isofluorane. During sur-
gery, body temperature was maintained at 37C with a warming pad. After
application of local anesthetics (lidocaine), a sagittal incision of the skin was
made above the supra-pelvic flank to expose the subcutaneous inguinal fat
pad. An imaging chamber was custom built to minimize fat movement. Warm
imaging solution (in millimolar: 130 NaCl, 3 KCl, 2.5 CaCl2, 0.6 MgCl2 , 6H2O,
10 HEPES without Na, 1.2 NaHCO3, 10 glucose (pH 7.45), with NaOH) (37
C)
mixedwith a fat dye (LipidTOX)was applied to label adipocytes,maintain tissue
integrity, and allow the use of immersion objective. Imaging experiments were
performed under a two-photon laser-scanning microscope (Ultima, Prairie In-
struments). Live images were acquired at 8–12 frames per second, at depths
below the surface ranging from 100 to 250 mm, using an Olympus 203 0.8
N.A. water immersion objective, with a laser tuned to 860–940 nmwavelength,
and emission filters 525/50 nm and 595/50 nm for green and red fluorescence,
respectively. Laser power was adjusted to be 20–25 mW at the focal plane
(maximally, 35 mW), depending on the imaging depth and level of expression
of dtTomato andLipidTOX spread. tdTomato fluorescencewas used to identify
TH-positive fibers until photobleaching occurred.
Leptin Treatment and Lipolysis Analysis
To examine the effect of leptin treatment on lipolysis, leptin (delivery rate of
500 ng/hr) or saline was delivered through osmotic pumps (Alzet) subcutane-
ously for 2 days. Body weight was recorded daily. Body fat composition was
measured using the EchoMRI body analyzer at end point before subcutaneous
or epididymal adipose tissues were collected. HSL phosphorylation was
detected by immunohistochemistry of paraffin sections at 6-mm thickness
and/or western blot of subcutaneous or epididymal adipose tissues. NE levels
in serum and subcutaneous fat pads were determined with an NE ELISA kit
(Labor Diagnostika Nord GmbH). Tissues were homogenized and sonicated
in homogenization buffer (1 N HCl, 1 mM EDTA), and cellular debris was pel-
leted by centrifugation at 13,000 rpm for 15 min at 4C. All tissue samples
were normalized to total tissue protein concentration.
Mechanical Denervation
The nerve bundle 2 mm distal from the tip of the epididymal fat was physically
crushed for 30 s and then released using a forcep. Leptin was administrated
through osmotic pump 3 days after nerve crush. HSL phosphorylation was
detected 2 days upon leptin treatment.
Hexamethonium Chloride, Isopreterenol, and a-Blocker Treatment
Hexamethonium chloride (500 mg/hr) was administrated during leptin treat-
ment through a separate osmotic pump, and the a-blockers phentolamine
(5 mg/kg, intraperitoneally [i.p.]) and phenoxybenzamine (10 mg/kg; i.p.)
were administrated twice a day during the course of leptin treatment
(500 ng/hr). Isopreterenol (250 mg per mouse) was delivered in saline through
jugular vein injection. Blood was drawn through tail bleeding, and plasma
FFA was measured using a NETO kit (Wako Pure Chemicals Industries). For
FFA release upon isopreterenol treatment in vitro, adipose tissue explants
were dissected and cultured in Hank’s medium and stimulated with isoprete-
nerol at 10 mg/ml for 3 hr. FFA was measured in the medium.
NE Measurements after Optogenetic Stimulation Ex Vivo
SCG were removed from 28- to 30-day-old TH-Cre X Rosa26-LSL-ChR2-YFP
mice under a stereomicroscope and placed in DMEM (Invitrogen). Ganglia
were cleaned from the surrounding tissue capsule and transferred into eight-
well tissue culture chambers (Sarstedt) that were previously coated with
poly-D-lysine (Sigma-Aldrich) in accordance to the manufacturer’s instruc-
tions. Ganglia were then covered with 5 ml Matrigel (BD Biosciences) and incu-
bated for 7 min at 37C. DMEM without phenol red (Invitrogen) supplemented
with 10% fetal bovine serum (Invitrogen), 2 mM L-glutamine (Biowest), and
nerve growth factor (Sigma-Aldrich) was subsequently added. SCG ganglia
were cultured for a minimum of 24 hr prior to further manipulation. Depolariza-
tion of sympathetic neurons in explant cultures was performed on a Yokogawa
CSU-X1 Spinning Disk confocal system using the 488-nm laser line and point-
ing at the region of interest (ROI) for 200 ms. Stimulation was repeated five
times using 40% of laser intensity. NE in the SCG explant culture medium
was determined with an NE ELISA kit (Labor Diagnostika Nord GmbH). The
same procedure was performed for LSL-ChR2-YFP control mice.
Surgeries and Optogenetic Stimulation
General anesthesia was induced and maintained with isofluorane. After appli-
cation of local anesthetics (lidocaine), a sagittal incision of the skin was made
above the neck and supra-pelvic flank. A hemostat was inserted into the inci-
sion and, by opening and closing the jaws of the hemostat, spread the subcu-
taneous tissue to create a longitudinal pocket for the optical fiber. The pocket
was made long enough to allow about 4–6 cm of fiber (Thorlabs FT200). The
tip of the fiber targeted the anatomical location of the inguinal fat pad. The
other end of the fiber, the ferrule-connector end, was secured along the skin
via sutures and dermal staples. Appropriate local analgesic was used post-
surgically. Optogenetical stimulations were performed 48 hr after surgical
procedures.
The stimulation session in Figure 4D lasted 4–6 hr and was performed via
a 1-s 20-Hz pulse of blue laser every other second, originating from a 473-
nm solid laser source (OEM-BL-473-00100-CWM-SD-05). The laser source
had an output power of 100 mW. Ferrule-coupled optical fibers of 200-mm
diameter (Thorlabs; FT200EMT-CANNULA-TS1031629) were connected to
ferrule patch cords (Thorlabs; FT200EMT-FC/PC-ferrule) with mating sleeves
(Thorlabs; ADAF1), and the later to the laser source via FC/PC adaptor.
NE in subcutaneous fad pads was determined with an NE ELISA kit (Labor
Diagnostika Nord GmbH) as described earlier.
Stimulation protocol in Figure 4E took place every day for 2 weeks and solely
during the rodent rest period. Longer sessions, as in Figure 4F, had a duration
of 4 weeks. Stimulation sessions lasted 4–6 hr and were performed as
described earlier.
MRI Fat Measurements and Fat Pad Segmentation
Mice were subjected to optogenetic stimulation as stated earlier, perfused
with 4% PFA/PBS, post-fixed over 2–3 days, and embedded in Fomblin Oil
(Sigma-Aldrich) for scanning. Imaging was performed on a 7.0 T 70/30 Bruker
Biospec small-animal MRI system with a 12-cm diameter 450 mT/m ampli-
tude and 4,500 T/m/s slew rate actively shielded gradient subsystems with
integrated shim capability. A linear coil with 7-cm diameter and a length suf-
ficient to cover the whole body of the animal was used for excitation and
reception of the magnetic resonance signal. Two image sets were acquired,
one with fat suppression and one without. Axial images, covering the whole
animal in 75 0.4-mm-thick slices without gap, were acquired in an interleavedway by using a RARE (rapid acquisition with relaxation enhancement) pulse
sequence with RARE factor 2. Four averages with a flip angle of 90—echo
time (TE) = 10 ms, repetition time (TR) = 2,468 ms, field of view = 10 3
3 cm, and matrix size = 2563 128 (acquisition matrix size = 2563 96), result-
ing in a spatial resolution of 0.391 3 0.234 3 0.4 mm—were acquired. The fat
suppression, added to the second scan, consists of a 90 Gaussian pulse
with 2.6067-ms duration and 1051.1-Hz bandwidth. Data were converted
into .tif files by FIJI software. The subcutaneous inguinal fat distribution
was determined with semi-automated Amira V5.3 software segmentation of
scanned images. Amira V5.3 software segmentation relies on the automated
grouping of pixels with the same index of intensity in the grayscale. An auto-
matic segmentation based on the gray threshold levels, which decomposes
the image domain into subsets, allowed us to define the right and the left
inguinal fat depots, which were further saved as unique fields. Volumes of
the right and the left subcutaneous fat pads were defined as the number of
voxels multiplied by the size of a single voxel. The size of stimulated fat
pads was determined, and the effect of optogenetic stimulation of neurons
on fat mass was calculated in the same animal relative to non-stimulated
contralateral side.
Statistical Methods
Statistics were performed in GraphPad Prism and involved the computation of
means and SEM, which accompany each figure legend. Student’s t tests and
ANOVAs were used where appropriate, and p values are indicated in text.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and two movies and can be found with this article online at
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